The Schwab U.S. Dividend Equity ETF (SCHD) has completed its annual reconstitution, significantly increasing its allocation to high-yield dividend stocks in the healthcare sector. The ETF now features UnitedHealth and Abbott Laboratories among its top ten holdings, reflecting a strategic shift that enhances its exposure to healthcare from 15.4% to 18.9%. This adjustment comes as the fund removed 22 stocks and added 25 new ones, with a focus on those demonstrating strong dividend growth and financial stability.
This reallocation matters for investors as it positions SCHD to benefit from the robust dividend growth rates of its new healthcare holdings, which average 9.4% over the past five years, compared to 8.6% previously. While the fund’s overall yield remains stable at 3.4%, the enhanced growth potential of its new constituents could lead to improved total returns over time, making it an attractive option for income-focused investors.
As the healthcare sector continues to demonstrate resilience and growth, SCHD’s increased exposure could provide a dual advantage of income and capital appreciation, appealing to professionals seeking to optimize their portfolios in a shifting market landscape.
Source: fool.com